Dentsply Sirona Evaluating Strategic Alternatives for Bladder, Bowel Management Products Business

Dow Jones

Feb 11, 2025

By Denny Jacob

Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.

Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply.

"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business," said Chief Executive Simon Campion.

The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

February 11, 2025 09:04 ET (14:04 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2510384983"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510384983\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2510384983?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-11 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510384983","market":"sh","top_or_hot":-1,"title":"Dentsply Sirona Evaluating Strategic Alternatives for Bladder, Bowel Management Products Business","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. \n</p>\n<p>\n  Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply. \n</p>\n<p>\n  \"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business,\" said Chief Executive Simon Campion. \n</p>\n<p>\n  The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 11, 2025 09:04 ET (14:04 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dentsply Sirona Evaluating Strategic Alternatives for Bladder, Bowel Management Products Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDentsply Sirona Evaluating Strategic Alternatives for Bladder, Bowel Management Products Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-11 22:04</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. \n</p>\n<p>\n  Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply. \n</p>\n<p>\n  \"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business,\" said Chief Executive Simon Campion. \n</p>\n<p>\n  The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 11, 2025 09:04 ET (14:04 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2510384983","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510384983","pubTimestamp":1739282640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply.\"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business,\" said Chief Executive Simon Campion.The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","XRAY":"登士柏国际"},"translate_title":"登士柏西诺德评估膀胱和肠道管理产品业务的战略替代方案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XRAY":1},"content_text":"By Denny Jacob \n\n\n \n\n\n  Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. \n\n\n  Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply. \n\n\n  \"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business,\" said Chief Executive Simon Campion. \n\n\n  The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction. \n\n\n \n\n\n  Write to Denny Jacob at denny.jacob@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 09:04 ET (14:04 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}